COO:NSD-The Cooper Companies, Inc. Common Stock (USD)

COMMON STOCK | Medical Instruments & Supplies |

Last Closing

USD 105.85

Change

0.00 (0.00)%

Market Cap

USD 21.47B

Volume

0.72M

Analyst Target

USD 346.82
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices for use in cesarean sections, illuminated speculum products, lone star retractor systems, loop electrosurgical excision procedure products, mara water ablation systems, paragard contraceptive IUDs, point-of-care, and uterine positioning products, as well as cryostorage, such as cord blood and cord tissue storage; fertility products and services, such as fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-03 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap
ISRG Intuitive Surgical Inc

N/A

USD 180.35B
HOLX Hologic Inc

N/A

USD 19.12B
ALGN Align Technology Inc

N/A

USD 15.58B
RGEN Repligen Corporation

N/A

USD 7.52B
MMSI Merit Medical Systems Inc

N/A

USD 5.76B
XRAY Dentsply Sirona Inc

N/A

USD 4.76B
ICUI ICU Medical Inc

N/A

USD 4.17B
AZTA Azenta Inc

N/A

USD 2.02B
LMAT LeMaitre Vascular Inc

N/A

USD 2.00B
ATRC AtriCure Inc

N/A

USD 1.63B

ETFs Containing COO

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Supplies) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -86.01% 5% F 3% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -86.01% 5% F 3% F
Trailing 12 Months  
Capital Gain -84.18% 2% F 4% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -84.18% 2% F 4% F
Trailing 5 Years  
Capital Gain -81.81% 7% C- 8% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return -81.81% 7% C- 8% B-
Average Annual (5 Year Horizon)  
Capital Gain 4.24% 47% F 51% F
Dividend Return 4.25% 47% F 48% F
Total Return 0.01% 20% F 1% F
Risk Return Profile  
Volatility (Standard Deviation) 24.51% 86% B+ 71% C-
Risk Adjusted Return 17.34% 63% D 51% F
Market Capitalization 21.47B 97% N/A 96% N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector